Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Huntsman Ronald Kirk
Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SOKOLOW LEONARD J
Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Thompson Matthew
Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Green Ralph Elias
Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Amman Bradford K.
Vivos Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-R. Kirk Huntsman(4.3%),Coronado V Partners, LLC(3.2%)
Vivos Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Huntsman Ronald Kirk
Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Huntsman Ronald Kirk
Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Huntsman Ronald Kirk
Vivos Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-R. Kirk Huntsman(9.0%),Coronado V Partners, LLC(6.0%)
Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities
Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities
Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities
Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities
Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities
Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities
Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities
Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities
Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities
No Data